R

Redhill Biopharma Ltd
D

RDHL

6.74000
USD
0.35
(5.48%)
Market Closed
Volume
0
EPS
-1
Div Yield
-
P/E
-0
Market Cap
8,630,833
OverviewSignalsIdeasNews
Related Instruments
    AZN
    AZN
    -1.830
    (-2.81%)
    64.255 USD
    B
    BCRX
    -0.41500
    (-5.57%)
    7.03500 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    I
    INO
    -0.54000
    (-11.25%)
    4.26000 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    99.85 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NNVC
    -0.11000
    (-8.27%)
    1.22000 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.14 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    V
    VSTM
    -0.13500
    (-3.26%)
    4.00000 USD
    More
News

Title: Redhill Biopharma Ltd

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company alsocommercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.